VYVGART Hytrulo (efgartigimod alfa and hyaluronidase (human recombinant))

**Product type:** Human Prescription Drug

**Active ingredient:** EFGARTIGIMOD ALFA; HYALURONIDASE (HUMAN RECOMBINANT)

**Strength:** 180; 2000 mg/mL; U/mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** argenx US

**Marketing category:** BLA (BLA761304)

**Pharmacologic class:** Endoglycosidase [EPC], Glycoside Hydrolases [CS], Neonatal Fc Receptor Blocker [EPC], Neonatal Fc Receptor Blockers [MoA]